Video Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan SeigermanBy adminMarch 23, 20240
Video Obesity weight loss market will remain a duopoly between Novo Nordisk and Eli Lilly: BofA’S MeachamBy adminJuly 1, 20230
Video Diabetes drug Mounjaro could be FDA approved for weight loss by late 2023: Eli LillyBy adminMay 7, 20230
